104 related articles for article (PubMed ID: 2626018)
1. Estrogens and the skeleton: cellular and molecular mechanisms.
Gray TK
J Steroid Biochem; 1989; 34(1-6):285-7. PubMed ID: 2626018
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta mediates the estrogen induced inhibition of UMR106 cell growth.
Gray TK; Lipes B; Linkhart T; Mohan S; Baylink D
Connect Tissue Res; 1989; 20(1-4):23-32. PubMed ID: 2612155
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.
Gray TK; Flynn TC; Gray KM; Nabell LM
Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6267-71. PubMed ID: 2819869
[TBL] [Abstract][Full Text] [Related]
5. Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation.
Fohr B; Schulz A; Battmann A
Exp Clin Endocrinol Diabetes; 2000; 108(6):414-23. PubMed ID: 11026755
[TBL] [Abstract][Full Text] [Related]
6. Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106.
Gray TK; Mohan S; Linkhart TA; Baylink DJ
Biochem Biophys Res Commun; 1989 Jan; 158(2):407-12. PubMed ID: 2916989
[TBL] [Abstract][Full Text] [Related]
7. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5.
Nasu M; Sugimoto T; Kaji H; Chihara K
J Endocrinol; 2000 Nov; 167(2):305-13. PubMed ID: 11054645
[TBL] [Abstract][Full Text] [Related]
8. Biochemical effects of 17 beta-estradiol on UMR106 cells.
Bankson DD; Rifai N; Williams ME; Silverman LM; Gray TK
Bone Miner; 1989 Apr; 6(1):55-63. PubMed ID: 2568866
[TBL] [Abstract][Full Text] [Related]
9. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.
Migliaccio S; Davis VL; Gibson MK; Gray TK; Korach KS
Endocrinology; 1992 May; 130(5):2617-24. PubMed ID: 1572285
[TBL] [Abstract][Full Text] [Related]
10. Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells.
Slootweg MC; Swolin D; Netelenbos JC; Isaksson OG; Ohlsson C
J Endocrinol; 1997 Oct; 155(1):159-64. PubMed ID: 9390018
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the action of 17 beta-estradiol and progestins with insulin-like growth factors-I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells.
Verhaar HJ; Damen CA; Duursma SA; Scheven BA
Maturitas; 1995 Apr; 21(3):237-43. PubMed ID: 7616873
[TBL] [Abstract][Full Text] [Related]
12. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells.
Schwartz Z; Carnes DL; Pulliam R; Lohmann CH; Sylvia VL; Liu Y; Dean DD; Cochran DL; Boyan BD
J Periodontol; 2000 Aug; 71(8):1287-96. PubMed ID: 10972644
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of mitogenic action of aluminum ion on human bone cells: potential involvement of the insulin-like growth factor regulatory system.
Lau KH; Utrapiromsuk S; Yoo A; Mohan S; Strong DD; Baylink DJ
Arch Biochem Biophys; 1993 Jun; 303(2):267-73. PubMed ID: 7685579
[TBL] [Abstract][Full Text] [Related]
14. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.
Yokose S; Ishizuya T; Ikeda T; Nakamura T; Tsurukami H; Kawasaki K; Suda T; Yoshiki S; Yamaguchi A
Endocrinology; 1996 Feb; 137(2):469-78. PubMed ID: 8593791
[TBL] [Abstract][Full Text] [Related]
15. Mechanical strain stimulates ROS cell proliferation through IGF-II and estrogen through IGF-I.
Cheng Mz; Zaman G; Rawlinson SC; Mohan S; Baylink DJ; Lanyon LE
J Bone Miner Res; 1999 Oct; 14(10):1742-50. PubMed ID: 10491222
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone.
Chen TL; Liu F; Bates RL; Hintz RL
Endocrinology; 1991 May; 128(5):2489-96. PubMed ID: 1708337
[TBL] [Abstract][Full Text] [Related]
17. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
[TBL] [Abstract][Full Text] [Related]
18. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
